Maude Cejudo Physical Therapy

01/12/2026

Medical tourism , focused US noninvasive prostate Ca, insightech

Insightec's focused ultrasound just made cancer surgery obsolete for prostate, liver, and bone tumors. No incisions, no anesthesia, no recovery time—just targeted sound waves destroying tumors while patients stay fully awake and walk out 30 minutes later ⚡

The physics is remarkable: Over 1,000 ultrasound beams converge on a tumor from different angles, each beam harmless individually. Where they intersect, the temperature spikes to 85°C (185°F), instantly vaporizing cancer tissue. MRI guidance ensures millimeter precision. The body naturally absorbs dead cells over 2-3 weeks. Patients experience what feels like deep warmth. The entire procedure takes 20 minutes per tumor site. Success rate matches surgical removal without the 6-week recovery, infection risks, or anesthesia complications.

Here's the pricing scandal: Developed in Israel using joint U.S.-Israeli research funding, the treatment costs $12,000 at Sheba Medical Center in Tel Aviv. American hospitals charge $35,000-$45,000 for identical procedures using the same Insightec machines. Why? U.S. hospitals add facility fees, anesthesiologist standby charges (despite not using anesthesia), and "advanced technology surcharges." Insurance companies negotiate rates that keep prices high to justify premium increases. Medical tourism companies now offer Tel Aviv packages—$12,000 treatment + round-trip flight + 4-night hotel stay = still $8,000 cheaper than U.S. treatment alone.

Every year, 268,000 American men get diagnosed with prostate cancer. Most face surgery with 40% erectile dysfunction rates and 15% incontinence. The non-invasive alternative exists, developed partly with their tax dollars, but costs triple domestically while being affordable overseas.

Should Americans pay 300% markups for technology their government helped fund?

📊 Source: Insightec Clinical Data & Sheba Medical Center, August 2025

01/08/2026

4~6 prunes , low glycemic index

The Prune Study was a 12-month, single-center randomized controlled trial designed to evaluate the effects of daily prune consumption on bone mineral density in postmenopausal women. A total of 235 women, with a mean age of approximately 62 years, were randomized to one of three groups: no prunes (control), 50 g of prunes per day, or 100 g of prunes per day. Bone mineral density at the total hip, lumbar spine, and whole body, along with bone turnover markers, was assessed at baseline, 6 months, and 12 months. The study aimed to determine whether a simple dietary intervention could mitigate bone loss commonly associated with menopause and reduce osteoporosis risk.

After 12 months, women consuming 50 g of prunes daily experienced significantly less loss of total hip bone mineral density compared with the control group, which showed a notable decline. The 50 g prune group largely maintained hip bone density, whereas the 100 g group did not demonstrate additional benefits and had lower adherence. These findings suggest that moderate daily prune intake may be an effective, well-tolerated, nonpharmacological strategy to help preserve hip bone density in postmenopausal women, potentially contributing to reduced fracture risk and improved long-term skeletal health.

PMID: 35798020

01/08/2026

Beginning studies in humans

Italian scientists found enzyme clearing arterial plaque reversing heart disease without surgery. Researchers at the University of Milan discovered that an enzyme called PLTP (phospholipid transfer protein) can mobilize cholesterol from arterial plaques back into the bloodstream for disposal. Enhanced PLTP activity reversed atherosclerosis in animal models, opening severely blocked arteries without drugs or procedures.

Atherosclerosis—arterial plaque buildup—causes heart attacks and strokes by blocking blood flow. Plaques form when cholesterol accumulates in artery walls, triggering inflammation that creates stable deposits resistant to removal. Current treatments lower cholesterol production or absorption to prevent new plaques, but can't reverse existing ones. Severe blockages require stents or bypass surgery to restore blood flow.

PLTP functions as the body's natural plaque-removal system, extracting cholesterol from arterial walls and transferring it to HDL ("good cholesterol") for transport to the liver and elimination. Italian scientists discovered that PLTP activity is naturally low in most people due to genetic variations, allowing plaque to accumulate. They developed a gene therapy that increases PLTP expression specifically in arterial walls.

Animal studies showed 40% reduction in plaque volume within three months—severely narrowed arteries reopening to near-normal diameter. Plaques became smaller and more stable (less likely to rupture and cause heart attacks). Human trials are recruiting patients with severe coronary artery disease who aren't surgical candidates. Success could revolutionize cardiovascular treatment—dissolving plaques biologically rather than mechanically bypassing them, potentially reversing decades of arterial damage.

Source: University of Milan, Circulation Research 2025

01/07/2026

American researchers reprogrammed fat cells into insulin producing cells curing diabetes naturally. Scientists at UCSF discovered a method to convert white adipose (fat) tissue into functional pancreatic beta cells that monitor blood glucose and secrete insulin appropriately. This cellular reprogramming cured diabetes in mice and is entering human trials, potentially offering permanent diabetes cure using patients' own abundant fat tissue.

Type 1 diabetes destroys insulin-producing beta cells; type 2 involves beta cell dysfunction and death. Both require lifelong blood sugar management. Replacing beta cells would cure diabetes, but sourcing them is problematic—donated pancreases are scarce, and lab-grown beta cells are expensive. UCSF's solution is elegant: convert the body's abundant fat cells into insulin-producing cells using genetic reprogramming.

The process extracts a small amount of abdominal fat through minor liposuction, treats cells with transcription factors that reprogram their identity, converting them into cells functionally identical to pancreatic beta cells. These reprogrammed cells sense glucose concentrations and release precise insulin amounts—exactly mimicking natural beta cell function. The cells are then injected into the liver where they engraft and begin controlling blood sugar.

Diabetic mice receiving reprogrammed cells achieved normal blood glucose within two weeks and remained non-diabetic for 12+ months without immunosuppression—because the cells came from their own bodies. Human trials beginning in 2026 will treat type 1 diabetics who've lost all beta cells. Success means permanent diabetes cure from a simple fat tissue donation, no donor organs needed, no immune rejection risk. We're potentially ending diabetes as a chronic disease.

Source: University of California San Francisco, Cell Stem Cell 2025

01/06/2026

Definitely a new treatment by Insightec

Researchers have developed a groundbreaking technique using focused sound waves to target and break down harmful protein plaques in the brains of Alzheimer’s patients, offering new hope for restoring memory and cognitive function. These plaques, composed of beta-amyloid proteins, are a hallmark of Alzheimer’s disease and contribute to neural degeneration and memory loss.

The procedure uses non-invasive ultrasound technology to direct sound waves precisely at affected brain regions. These waves disrupt the plaques and stimulate the brain’s natural cleaning system, helping to remove the toxic buildup without surgery or medication. Early clinical trials have shown promising results, with patients demonstrating improved memory recall, learning ability, and cognitive performance after treatment.

Scientists emphasize that this approach is both safe and highly targeted, minimizing side effects while activating the brain’s own mechanisms for repair. Unlike traditional treatments that often only manage symptoms, focused sound therapy tackles one of the disease’s root causes, potentially slowing or even reversing its progression.

Beyond Alzheimer’s, the research opens doors for treating other neurodegenerative disorders linked to protein aggregation, such as Parkinson’s disease. By harnessing technology to work in harmony with natural brain processes, scientists are pioneering innovative solutions to some of the most challenging neurological conditions.

This breakthrough represents a remarkable step toward restoring memory, improving quality of life, and reshaping the future of Alzheimer’s treatment, showing that even in a damaged brain, regeneration may be possible.

01/05/2026

Shift of perspective on how brain connects

Your brain quietly glows with tiny flashes of living light

Scientists have discovered that neurons emit ultra weak light called biophotons. These are not reflections or imagination. They are real particles of light produced during normal brain activity. When neurons fire, chemical reactions inside them can release faint photons. This glow is far below what your eyes can see, but sensitive instruments can detect it. The idea that the brain uses light sounds wild, yet it is grounded in measurable physics and biology.

Researchers believe these biophotons may play a role in how brain cells communicate internally. Some theories suggest light could help coordinate activity inside neurons faster than chemical signals alone. This does not mean thoughts are made of light or that consciousness is solved. But it does hint that the brain may be more complex than electrical signals and chemicals. Light has already been shown to guide processes in cells, DNA repair, and energy regulation. The brain may be using the same ancient biological tool in ways we are only beginning to explore.

For you, this discovery invites a shift in perspective. Consciousness may not be just wiring and impulses. It may involve subtle processes we are only now learning to measure. Your thoughts, memories, and awareness emerge from a system more elegant than expected. A brain that sparks. A mind that glows quietly while you live your life. Science has not answered what consciousness is yet. But each discovery like this brings us closer to understanding how extraordinary being human truly is.

12/26/2025

Read the comments for better view.

Researchers in Germany are exploring a new diabetes treatment approach focused on repairing insulin-producing pancreatic cells. The goal is to restore natural insulin function rather than manage symptoms indefinitely.

Early studies indicate these cells may regenerate more effectively than once believed. Scientists are testing ways to stimulate recovery and regain normal blood-sugar regulation.

Unlike traditional diabetes care, this strategy targets the root biological damage. It aims to reduce long-term dependence on insulin injections and constant glucose monitoring.

Experts say regenerative medicine could redefine chronic disease treatment. Instead of lifelong control, future therapies may prioritize cellular repair and functional restoration.

Although still under investigation, the research highlights Germany’s leadership in advanced medical innovation. If validated, this approach could dramatically change how diabetes is treated worldwide.

12/18/2025

Simple to start with exercises for feet!!

12/18/2025

Time to get a new perspective on what helps.

Researchers have found that modulating background brain activity with gentle electrical stimulation restored neural balance and improved ADHD attention in a randomized trial.

Read our coverage of the study via the link in the comments.